These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 8475106)

  • 21. A His19 to Ala mutant of melanoma growth-stimulating activity is a partial antagonist of the CXCR2 receptor.
    Baly DL; Horuk R; Yansura DG; Simmons LC; Fairbrother WJ; Kotts C; Wirth CM; Gillece-Castro BL; Toy K; Hesselgesser J; Allison DE
    J Immunol; 1998 Nov; 161(9):4944-9. PubMed ID: 9794430
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of a receptor for human monocyte-derived neutrophil chemotactic factor/interleukin-8.
    Grob PM; David E; Warren TC; DeLeon RP; Farina PR; Homon CA
    J Biol Chem; 1990 May; 265(14):8311-6. PubMed ID: 2186041
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparative study of the neutrophil stimulatory activity in vitro and pro-inflammatory properties in vivo of 72 amino acid and 77 amino acid IL-8.
    Nourshargh S; Perkins JA; Showell HJ; Matsushima K; Williams TJ; Collins PD
    J Immunol; 1992 Jan; 148(1):106-11. PubMed ID: 1727857
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CXCL8((3-73))K11R/G31P antagonizes ligand binding to the neutrophil CXCR1 and CXCR2 receptors and cellular responses to CXCL8/IL-8.
    Li F; Zhang X; Gordon JR
    Biochem Biophys Res Commun; 2002 May; 293(3):939-44. PubMed ID: 12051749
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amino terminus of the interleukin-8 receptor is a major determinant of receptor subtype specificity.
    LaRosa GJ; Thomas KM; Kaufmann ME; Mark R; White M; Taylor L; Gray G; Witt D; Navarro J
    J Biol Chem; 1992 Dec; 267(35):25402-6. PubMed ID: 1281158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibodies against the N-terminus of IL-8 receptor A inhibit neutrophil chemotaxis.
    Quan JM; Martin TR; Rosenberg GB; Foster DC; Whitmore T; Goodman RB
    Biochem Biophys Res Commun; 1996 Feb; 219(2):405-11. PubMed ID: 8605000
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural requirements for interleukin-8 function identified by design of analogs and CXC chemokine hybrids.
    Clark-Lewis I; Dewald B; Loetscher M; Moser B; Baggiolini M
    J Biol Chem; 1994 Jun; 269(23):16075-81. PubMed ID: 8206907
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of human basophils through the IL-8 receptor.
    Krieger M; Brunner T; Bischoff SC; von Tscharner V; Walz A; Moser B; Baggiolini M; Dahinden CA
    J Immunol; 1992 Oct; 149(8):2662-7. PubMed ID: 1383321
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple sites on IL-8 responsible for binding to alpha and beta IL-8 receptors.
    Schraufstätter IU; Barritt DS; Ma M; Oades ZG; Cochrane CG
    J Immunol; 1993 Dec; 151(11):6418-28. PubMed ID: 8245475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Humanized forms of the CXCR1/CXCR2 antagonist, bovine CXCL8((3-74))K11R/G31P, effectively block ELR-CXC chemokine activity and airway endotoxemia pathology.
    Zhao X; Li F; Town JR; Zhang X; Wang W; Gordon JR
    Int Immunopharmacol; 2007 Dec; 7(13):1723-31. PubMed ID: 17996682
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthetic hexa- and heptapeptides that inhibit IL-8 from binding to and activating human blood neutrophils.
    Hayashi S; Kurdowska A; Miller EJ; Albright ME; Girten BE; Cohen AB
    J Immunol; 1995 Jan; 154(2):814-24. PubMed ID: 7814885
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mediators of neutrophil recruitment in human abdominal aortic aneurysms.
    Houard X; Touat Z; Ollivier V; Louedec L; Philippe M; Sebbag U; Meilhac O; Rossignol P; Michel JB
    Cardiovasc Res; 2009 Jun; 82(3):532-41. PubMed ID: 19201759
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synergy between proinflammatory ligands of G protein-coupled receptors in neutrophil activation and migration.
    Gouwy M; Struyf S; Catusse J; Proost P; Van Damme J
    J Leukoc Biol; 2004 Jul; 76(1):185-94. PubMed ID: 15075362
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of human neutrophil receptor-mediated uptake of N-formyl-met-leu-phe by platelet factor 4 (59-70).
    Goldman DW; Hannah AL; Goetzl EJ
    Immunology; 1985 Jan; 54(1):163-72. PubMed ID: 3838292
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The amino-terminal residues in the crystal structure of connective tissue activating peptide-III (des10) block the ELR chemotactic sequence.
    Malkowski MG; Lazar JB; Johnson PH; Edwards BF
    J Mol Biol; 1997 Feb; 266(2):367-80. PubMed ID: 9047370
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amino-terminal processing of chemokine ENA-78 regulates biological activity.
    Nufer O; Corbett M; Walz A
    Biochemistry; 1999 Jan; 38(2):636-42. PubMed ID: 9888803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human leukocyte elastase and cathepsin G are specific inhibitors of C5a-dependent neutrophil enzyme release and chemotaxis.
    Tralau T; Meyer-Hoffert U; Schröder JM; Wiedow O
    Exp Dermatol; 2004 May; 13(5):316-25. PubMed ID: 15140022
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure and functional expression of a human interleukin-8 receptor.
    Holmes WE; Lee J; Kuang WJ; Rice GC; Wood WI
    Science; 1991 Sep; 253(5025):1278-80. PubMed ID: 1840701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Receptor-binding conformation of the "ELR" motif of IL-8: X-ray structure of the L5C/H33C variant at 2.35 A resolution.
    Gerber N; Lowman H; Artis DR; Eigenbrot C
    Proteins; 2000 Mar; 38(4):361-7. PubMed ID: 10707023
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Responsiveness of human neutrophils to interleukin-4: induction of cytoskeletal rearrangements, de novo protein synthesis and delay of apoptosis.
    Girard D; Paquin R; Beaulieu AD
    Biochem J; 1997 Jul; 325 ( Pt 1)(Pt 1):147-53. PubMed ID: 9224640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.